Maximum quantity allowed is 999
请选择数量
CAS RN: 63659-19-8 | 产品编码: B4474
Betaxolol Hydrochloride
×
![]()
×
| 产品编码 | B4474 |
| 纯度/分析方法 | >98.0%(HPLC) |
| 分子式/分子量 | C__1__8H__2__9NO__3·HCl = 343.89 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 室温 (15°C以下阴凉干燥处) |
| 包装和容器 | 250MG-Glass Bottle with Plastic Insert （查看图片）, 50MG-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 63659-19-8 |
| 相关CAS RN | 63659-18-7 |
| Reaxys-RN | 5182512 |
| PubChem物质ID | 253662283 |
| Merck Index (14) | 1182 |
| MDL编号 | MFCD00242959 |
技术规格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 97.0 % |
| Melting point | 113.0 to 117.0 °C |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 115 °C |
| 溶解性（微溶于） | 丙酮 |
| 溶解性（不溶于） | 乙醚 |
GHS
| 象形图 |
|
| 信号词 | Warning |
| 危险性说明 | H302 : Harmful if swallowed. H361 : Suspected of damaging fertility or the unborn child. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P405 : Store locked up. |
相关法规
| RTECS# | UA9823000 |
运输信息
| HS编码* | 2922.50-000 |
应用
Betaxolol hydrochloride: A Selective β1-Adrenoceptor Antagonist with Ca2+ Channel-Blocking Activity.
Betaxolol hydrochloride is a selective β1-adrenoceptor antagonist with Ca2+ channel-blocking activity. Betaxolol hydrochloride also has been reported as a retinal neuroprotective agent. It is used for the treatment of hypertension and glaucoma. (The product is for research purpose only.)
References
- Synthesis of a series of compounds related to betaxolol, a new β1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases
- Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension
- Betaxolol, a β1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels
- In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent
- Topically applied betaxolol attenuates ischemia-induced effects to the rat retina and stimulates BDNF mRNA
- Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization
参考文献
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。